|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.22 USD | +6.05% |
|
-4.96% | -5.30% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| US$47.21 | +90.92% | 14 | |||||||
| CHF 673.39 | +29.95% | 23 | |||||||
| US$404.57 | +16.59% | 24 | |||||||
| US$257 | +42.02% | 20 | |||||||
| ₩238,933.59 | +9.85% | 22 | |||||||
| US$119.37 | +24.15% | 19 | |||||||
| US$545.75 | +0.83% | 12 | |||||||
| €70.26 | +2.63% | 15 | |||||||
| US$90.67 | +8.61% | 22 | |||||||
| US$233.7 | +27.73% | 16 | |||||||
| US$206.38 | +41.95% | 16 | |||||||
| US$74.27 | +12.77% | 11 | |||||||
| US$54.42 | +6.24% | 13 | |||||||
| US$215.73 | +17.44% | 15 | |||||||
| US$87.92 | +67.65% | 12 | |||||||
| €109.03 | +14.17% | 5 | |||||||
| US$570.38 | +86.63% | 16 | |||||||
| CN¥68.22 | +7.1% | 11 | |||||||
| Average | 13,486.77 | +28.18% | 16 | ||||||
| Weighted average by Cap. | 26,089.01 | +23.99% | 18 |
- Stock Market
- Equities
- BEAM Stock
- Sector Beam Therapeutics Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















